Elranatamab
id:
elranatamab-173-5078066
title:
Elranatamab
text:
Elranatamab, sold under the brand name Elrexfio, is a medication used for the treatment of multiple myeloma. Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. Elranatamab is given by subcutaneous injection. The most common side effects include cytokine release syndrome, fatigue, injection site reaction, diarrhea, upper respiratory tract infection, musculoskeletal pain, pneumonia, decreased appetite, rash, cough, nausea, and pyrexia (fever). Elranatamab was
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Elranatamab
date created:
2023-08-15T10:50:19Z
date modified:
2024-09-02T03:30:13Z
main entity:
{"identifier":"Q121549012","url":"https://www.wikidata.org/entity/Q121549012"}
image:
fields total:
13
integrity:
15